Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-07MGTX144Naylor Stuart plan to sell securities of MeiraGTx Holdings plc under Form 144MEDIUM
Naylor Stuart filed Form 144 to notify SEC of plan to sell 27661 units of MeiraGTx Holdings plc securities around 2026-04-07, with aggregate market value of $258,874.75. The total outstanding units is 81446126.0. The amount planned to be sold represents 0.03% of total outstanding units; ...
Small CapBiotechnology
2026-04-07MeiraGTx Holdings plc144Naylor Stuart plan to sell securities of MeiraGTx Holdings plc under Form 144DuplicateMEDIUM
Naylor Stuart filed Form 144 to notify SEC of plan to sell 27661 units of MeiraGTx Holdings plc securities around 2026-04-07, with aggregate market value of $258,874.75. The total outstanding units is 81446126.0. The amount planned to be sold represents 0.03% of total outstanding units; ...
Small CapBiotechnology
2026-04-07ACET144OrbiMed Israel Partners Limited Partnership plan to sell securities of Adicet Bio, Inc. under Form 144MEDIUM
OrbiMed Israel Partners Limited Partnership filed Form 144 to notify SEC of plan to sell 64242 units of Adicet Bio, Inc. securities around 2026-04-07, with aggregate market value of $413,076.06. The total outstanding units is 9596407.0. The amount planned to be sold represents 0.67% of total outstanding units; ...
Micro CapBiotechnology
2026-04-07KYTX144DANIEL SPIEGELMAN plan to sell securities of KYVERNA THERAPEUTICS, INC. under Form 144MEDIUM
DANIEL SPIEGELMAN filed Form 144 to notify SEC of plan to sell 17578 units of KYVERNA THERAPEUTICS, INC. securities around 2026-04-07, with aggregate market value of $162,636.93. The total outstanding units is 60439893.0. The amount planned to be sold represents 0.03% of total outstanding units; Recent transactions in ...
Small CapBiotechnology
2026-04-06ALNY144McLaughlin Melissa plan to sell securities of ALNYLAM PHARMACEUTICALS, INC. under Form 144MEDIUM
McLaughlin Melissa filed Form 144 to notify SEC of plan to sell 2286 units of ALNYLAM PHARMACEUTICALS, INC. securities around 2026-04-06, with aggregate market value of $731,748.60. The total outstanding units is 132623144.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Mega CapBiotechnology